Makers Laboratories Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 878419, "name": "Makers Labs.", "stock_name": "Makers Labs.", "full_name": "Makers Laboratories Ltd", "name_url": "stocks-analysis/makers-labs", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "155.60", "chg": 0.75, "chgp": "0.48%", "dir": 1, "prev_price": "154.85", "mcapval": "91.00 Cr", "mcap": "Micro Cap", "scripcode": 506919, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE987A01010", "curr_date": "Jul 29, 11:03 AM", "curr_time": "11:09 AM", "last_traded_at": "Jul 29, 11:03 AM IST", "bse_nse_vol": "52 ", "exc_status": "Active", "traded_date": "Jul 29, 2026", "traded_date_str": "2026 07 29", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/makers-labs-878419-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Makers Laboratories Ltd Downgraded to Sell Amid Valuation and Financial Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/makers-laboratories-ltd-downgraded-to-sell-amid-valuation-and-financial-concerns-4123591", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MakersLaborator_mojoScore_4123591.png", "date": "2026-07-28 08:24:06", "description": "Makers Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell by MarketsMOJO as of 27 July 2026. The revision primarily stems from a deterioration in valuation metrics, despite some positive quarterly financial trends and technical signals. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced the change in the company’s Mojo Grade to 47.0, signalling a Sell recommendation." }, { "title": "Makers Laboratories Ltd Valuation Shifts: From Attractive to Fair Amidst Sector Dynamics", "link": "https://www.marketsmojo.com/news/stocks-in-action/makers-laboratories-ltd-valuation-shifts-from-attractive-to-fair-amidst-sector-dynamics-4123190", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MakersLaborator_valuationdot_4123190.png", "date": "2026-07-28 08:01:05", "description": "Makers Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid rising price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the stock differently against its peers and historical benchmarks." }, { "title": "Makers Laboratories Ltd Upgraded to Hold on Improved Valuation and Financial Trends", "link": "https://www.marketsmojo.com/news/stock-recommendation/makers-laboratories-ltd-upgraded-to-hold-on-improved-valuation-and-financial-trends-4111909", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MakersLaborator_mojoScore_4111909.png", "date": "2026-07-21 08:22:27", "description": "Makers Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, driven primarily by an improved valuation profile and encouraging quarterly financial results. The micro-cap pharmaceutical company’s Mojo Score has risen to 50.0, reflecting a more balanced outlook amid mixed long-term fundamentals and recent operational progress." }, { "title": "Makers Laboratories Ltd Gains 1.05%: Downgrade and Valuation Shift Shape Weekly Moves", "link": "https://www.marketsmojo.com/news/stocks-in-action/makers-laboratories-ltd-gains-105-downgrade-and-valuation-shift-shape-weekly-moves-4107398", "imagepath": "", "date": "2026-07-18 15:00:06", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>13 Jul:</strong> Stock opens at Rs.152.60, gaining 2.93% on the day</p>\n <p><strong>14 Jul:</strong> Mojo grade downgraded to Sell amid valuation concerns</p>\n <p><strong>15 Jul:</strong> Valuation grade shifts from attractive to fair</p>\n <p><strong>17 Jul:</strong> Week closes at Rs.149.80, up 1.05% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.152.60</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.149.80</di..." }, { "title": "Makers Laboratories Ltd Downgraded to Sell Amid Valuation and Financial Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/makers-laboratories-ltd-downgraded-to-sell-amid-valuation-and-financial-concerns-4103246", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MakersLaborator_mojoScore_4103246.png", "date": "2026-07-15 08:11:14", "description": "Makers Laboratories Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a reassessment across key parameters including valuation, financial trends, quality, and technical indicators. Despite some positive quarterly results, concerns over long-term profitability and valuation metrics have prompted this change, signalling caution for investors in the pharmaceuticals sector." }, { "title": "Makers Laboratories Ltd Valuation Shifts Amid Sector Dynamics", "link": "https://www.marketsmojo.com/news/stocks-in-action/makers-laboratories-ltd-valuation-shifts-amid-sector-dynamics-4102945", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MakersLaborator_valuationdot_4102945.png", "date": "2026-07-15 08:00:58", "description": "Makers Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change reflects evolving market perceptions amid a challenging Pharmaceuticals & Biotechnology sector landscape, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios adjusting relative to historical averages and peer benchmarks." }, { "title": "Makers Laboratories Ltd Upgraded to Hold on Improved Valuation and Financial Trends", "link": "https://www.marketsmojo.com/news/stock-recommendation/makers-laboratories-ltd-upgraded-to-hold-on-improved-valuation-and-financial-trends-4091688", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MakersLaborator_mojoScore_4091688.png", "date": "2026-07-07 08:30:17", "description": "Makers Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, driven primarily by an improved valuation profile and positive financial trends. The micro-cap pharmaceutical company’s recent performance and comparative metrics have prompted a reassessment of its quality, valuation, financial trend, and technical outlook, culminating in a more favourable stance by analysts." }, { "title": "Makers Laboratories Ltd Valuation Shifts: From Attractive to Fair Amidst Sector Dynamics", "link": "https://www.marketsmojo.com/news/stocks-in-action/makers-laboratories-ltd-valuation-shifts-from-attractive-to-fair-amidst-sector-dynamics-4089887", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MakersLaborator_valuationdot_4089887.png", "date": "2026-07-06 08:01:15", "description": "Makers Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade as of late June 2026. This change reflects evolving market perceptions amid fluctuating price-to-earnings (P/E) and price-to-book value (P/BV) ratios, set against a backdrop of sector-wide valuation trends and company-specific performance metrics." }, { "title": "Makers Laboratories Ltd Declines 0.95%: Valuation and Profitability Concerns Weigh", "link": "https://www.marketsmojo.com/news/stocks-in-action/makers-laboratories-ltd-declines-095-valuation-and-profitability-concerns-weigh-4088794", "imagepath": "", "date": "2026-07-04 15:01:51", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>29 Jun:</strong> Valuation shifts from attractive to fair</p>\n <p><strong>30 Jun:</strong> Downgrade to Sell rating announced</p>\n <p><strong>2 Jul:</strong> Sharp 8.05% price jump amid sector gains</p>\n <p><strong>3 Jul:</strong> Price retreats 5.96% to close the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.152.90</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.151.45</div><div class=\"stat-change negative\">-0.95%</di..." } ], "total": 143, "sid": "878419", "stock_news_url": "https://www.marketsmojo.com/news/makers-laboratories-878419" }, "announcements": [ { "caption": "Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For The 1St Quarter Ended June 30 2026", "datetime": "23-Jul-2026", "details": "Makers Laboratories Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results for the 1st quarter ended June 30 2026", "source": "BSE" }, { "caption": "Intimation To Shareholders Regarding Weblink Of Annual Report", "datetime": "13-Jul-2026", "details": "Intimation to shareholders regarding weblink of Annual Report", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "13-Jul-2026", "details": "Copy of Newspaper Publication", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "07 Aug 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Makers Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 01 Aug 19", "dt": "2019-08-01", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Makers Laboratories Ltd has announced <strong>1:5</strong> rights issue, ex-date: 30 Mar 22", "dt": "2022-03-30", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

13 Jul: Stock opens at Rs.152.60, gaining 2.93% on the day

14 Jul: Mojo grade downgraded to Sell amid valuation concerns

15 Jul: Valuation grade shifts from attractive to fair

17 Jul: Week closes at Rs.149.80, up 1.05% for the week

Week Open

Rs.152.60

Week Close

Rs.149.80Read full news article

Makers Laboratories Ltd Downgraded to Sell Amid Valuation and Financial Concerns

2026-07-15 08:11:14

Makers Laboratories Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a reassessment across key parameters including valuation, financial trends, quality, and technical indicators. Despite some positive quarterly results, concerns over long-term profitability and valuation metrics have prompted this change, signalling caution for investors in the pharmaceuticals sector.

Read full news article

Makers Laboratories Ltd Valuation Shifts Amid Sector Dynamics

2026-07-15 08:00:58

Makers Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change reflects evolving market perceptions amid a challenging Pharmaceuticals & Biotechnology sector landscape, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios adjusting relative to historical averages and peer benchmarks.

Read full news article

Makers Laboratories Ltd Upgraded to Hold on Improved Valuation and Financial Trends

2026-07-07 08:30:17

Makers Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, driven primarily by an improved valuation profile and positive financial trends. The micro-cap pharmaceutical company’s recent performance and comparative metrics have prompted a reassessment of its quality, valuation, financial trend, and technical outlook, culminating in a more favourable stance by analysts.

Read full news article

Makers Laboratories Ltd Valuation Shifts: From Attractive to Fair Amidst Sector Dynamics

2026-07-06 08:01:15

Makers Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade as of late June 2026. This change reflects evolving market perceptions amid fluctuating price-to-earnings (P/E) and price-to-book value (P/BV) ratios, set against a backdrop of sector-wide valuation trends and company-specific performance metrics.